Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
NEW! NEW!
New Jersey Department of Children and Families
Trenton, New Jersey
CommonSpirit Health Research Institute
San Luis Obispo, California
NEW! NEW!
Akron Children's - Physician Recruitment
Boardman, Ohio
NEW! NEW!
NEW! NEW!
NEW! NEW!
Memorial Sloan Kettering Cancer Center
New York, New York
NEW! NEW!
NEW! NEW!
NEW! NEW!
Duke University Health System
Durham, North Carolina
NEW! NEW!
Vanderbilt Health
Nashville, Tennessee
NEW! NEW!
Fred Hutchinson Cancer Center
Seattle, Washington
NEW! NEW!
Indiana University Health
Indianapolis, Indiana
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
Loading... Please wait.
Executive Director, Trial Operations
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, USA – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b
Loading. Please wait.